SCHEMBL91941

SCHEMBL91941

Cc1ccc(-c2ccc(-c3ccc(Cl)cc3)c(F)c2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 2/20 0.41
PDE3B Q13370 2/20 0.40
PDE3A Q14432 2/20 0.40
APEX1 P27695 1/20 0.39
GRM2 Q14416 1/20 0.38
MALT1 Q9UDY8 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
APP P05067 1/20 0.38
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
PTGS2 P35354 2/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741569 0.96 APEX1 (0.41) PTGES2PDE3BPDE3AAPEX1GRM2
SCHEMBL91817 0.89 PDE3B (0.43) PTGES2PDE3BPDE3AGRM2PTGS2
SCHEMBL14206977 0.89 PTGES2 (0.46) PTGES2PDE3BPDE3AAPEX1PTGS2
SCHEMBL803426 0.88 PDE3B (0.48) PDE3BPDE3AAPPAKR1C3AKR1C2
SCHEMBL4567632 0.86 PDE3B (0.47) PDE3BPDE3AAPPAKR1C3AKR1C2
SCHEMBL12889477 0.86 NFE2L2 (0.47) PDE3BPDE3AAKR1C3AKR1C2PTGS2
SCHEMBL12826296 0.86 NFE2L2 (0.47) PDE3BPDE3AAKR1C3AKR1C2PTGS2
SCHEMBL13417748 0.86 PTGES2 (0.43) PTGES2PDE3BPDE3AAPEX1GRM2
SCHEMBL13967517 0.86 PTGS2 (0.46) PDE3BPDE3AAPPAKR1C3AKR1C2
SCHEMBL12696815 0.85 PSEN1 (0.44) PDE3BPDE3APSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 601 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043782-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 US disclosed
US-12043781-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 US disclosed
US-12043782-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 US disclosed
US-20240072425-A1 AROMATIC ISOTHIOCYANATES MERCK PATENT GMBH (DE) 2024-02-29 US disclosed
US-20240072425-A1 AROMATIC ISOTHIOCYANATES MERCK PATENT GMBH (DE) 2024-02-29 US disclosed
WO-2024017812-A1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2024-01-25 WO disclosed
US-11834599-B2 Aromatic isothiocyanates MERCK PATENT GMBH (DE) 2023-12-05 US disclosed
US-11834599-B2 Aromatic isothiocyanates MERCK PATENT GMBH (DE) 2023-12-05 US disclosed
US-20230383186-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-11-30 US disclosed
US-20230383186-A1 LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2023-11-30 US disclosed
US-20080199635-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GESELLSCHAFT (DE) 2008-08-21 US disclosed
US-20080167482-A1 mesogenic group is linked to the C-atom No. 5 of the 1,3-dioxane-5-yl group; media showing a blue phase and their use in electro-optical light modulation elements MERCK PATENT GMBH (DE) 2008-07-10 US disclosed
US-7390538-B2 Liquid-crystal medium containing monofluoroterphenyl compounds MERCK PATENT GMBH (DE) 2008-06-24 US disclosed
US-20080116419-A1 Mesogenic Compounds, Liquid Crystal Medium and Liquid Crystal Display MERCK PATENT GMBH (DE) 2008-05-22 US disclosed
US-20080083904-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-10 US disclosed
US-20070237907-A1 PHOTOSTABLE LIQUID-CRYSTALLINE MEDIUM MANABE ATSUTAKA 2007-10-11 US disclosed
US-20070176146-A1 Liquid-crystalline medium and liquid-crystal display MERCK PATENT GMBH (DE) 2007-08-02 US disclosed
US-20070170395-A1 Liquid crystal medium MERCK PATENT GESELLSCHAFT 2007-07-26 US disclosed
US-7211302-B2 Photostable liquid crystalline medium MERCK PATENT GMBH (DE) 2007-05-01 US disclosed
US-20070001149-A1 Liquid-crystal medium containing monofluoroterphenyl compounds MERCK PATENT GMBH (DE) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240072425-A1 AROMATIC ISOTHIOCYANATES TRPA1, TRPC1, CRY1 PTGES2 4478/4885PDE3B 3262/4885PDE3A 3309/4885
US-20080083904-A1 LIQUID-CRYSTALLINE MEDIUM NEFM, OSBP, ALPG PTGES2 3242/4885PDE3B 786/4885PDE3A 1198/4885
US-20080116419-A1 Mesogenic Compounds, Liquid Crystal Medium and Liquid Crystal Display CRY1, CRY2, IK PTGES2 1878/4885PDE3B 1399/4885PDE3A 1918/4885
US-20080199635-A1 LIQUID-CRYSTALLINE MEDIUM L1CAM, NEFM, CHRM1 PTGES2 3946/4885PDE3B 1953/4885PDE3A 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.